Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gingerol refers to a group of related phenolic compounds found in the rhizome of ginger (Zingiber officinale), with 6-gingerol being the major and most studied constituent. Gingerols are responsible for the pungent flavor of fresh ginger and are structurally characterized by a 4-hydroxy-3-methoxyphenyl group substituted at the C6 carbon atom by a hydroxyalkane ketone side chain. Gingerols exhibit various biological activities including anti-inflammatory, antioxidant, anticancer (antineoplastic), antifungal, and analgesic effects. Mechanistically, they modulate multiple cellular pathways involved in apoptosis (programmed cell death), inhibition of angiogenesis (formation of new blood vessels in tumors), cell cycle regulation, cytotoxicity against cancer cells, and free radical scavenging activity. Gingerol is not developed as a pharmaceutical drug but is widely studied for its potential therapeutic benefits as a natural product or dietary supplement[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gingerol.